SGMT Sagimet Biosciences Inc. - Series A Common Stock
$6,59
Fiyat · May 20, 2026
Temel veriler itibarıyla May 12, 2026
52 Haftlık Aralık
$3–$11
42% of range
Analist Derecelendirmesi
BUY
18 analysts
Fiyat Hedefi
$28
+332% upside
P/E (TTM)
-3.7
ROE
-42.3%
Net Kâr Marjı
—
SGMT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$6.59
Piyasa Değeri
—
P/E (TTM)
-3.7
EPS (TTM)
$-1.58
Gelir (TTM)
$2M
Temettü Verimi
—
ROE
-42.3%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$3 – $11
SGMT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$2M
2023-12-31
→
2023-12-31
Hisse Başına Kâr
$-1.58
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
SGMT
Akran Ortalaması
P/E (TTM)
-3.7
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
SGMT
Akran Ortalaması
ROA
-36.9%
-33.2%
ROE
-42.3%
-62.6%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
SGMT
Akran Ortalaması
Current Ratio (Cari Oran)
22.8
5.8
Quick Ratio (Cari Oran)
22.2
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
SGMT
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
SGMT
Akran Ortalaması
SGMT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
18 analist
- Güçlü Al 6 33,3%
- Al 10 55,6%
- Tut 2 11,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
10 analist · 2026-05-18
Medyan
$28.50
← Tüm hedeflerin altında
$6.59
Düşük
$8.00
Yüksek
$49.00
Medyan hedef
$28.50
+332,5%
Ortalama hedef
$28.50
+332,5%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.10%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.33 | $-0.38 | 0.05% |
| 31 Aralık 2025 | $-0.29 | $-0.41 | 0.12% |
| 30 Eylül 2025 | $-0.40 | $-0.39 | -0.01% |
| 30 Haziran 2025 | $-0.32 | $-0.52 | 0.20% |
| 31 Mart 2025 | $-0.56 | $-0.68 | 0.12% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| SGMT | — | -3.7 | — | — | -42.3% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| REPL | $752M | -3.2 | — | — | -55.1% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| MNPR | — | — | — | — | — | — |
| FBRX | $353M | -5.8 | 106.6% | -2555.2% | -86.9% | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | — |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 13
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | · | · | $2M | |
| R&D Expense | $39M | $38M | $20M | |
| SG&A Expense | $18M | $16M | $13M | |
| Operating Expenses | $57M | $54M | $33M | |
| Operating Income | $-57M | $-54M | $-31M | |
| Other Non-op | $6M | $9M | $3M | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-51M | $-46M | $-28M | |
| EPS (Basic) | $-1.58 | $-1.45 | $-2.66 | |
| EPS (Diluted) | $-1.58 | $-1.45 | $-2.66 | |
| Shares (Basic) | 32,345,525 | 31,350,725 | 10,460,335 | |
| Shares (Diluted) | 32,345,525 | 31,350,725 | 10,460,335 | |
| EBITDA | $-57M | $-54M | $-31M |
Bilanço 16
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $35M | $76M | $75M | |
| Short-term Investments | $78M | $75M | $20M | |
| Prepaid Expense | $3M | $2M | $2M | |
| Other Current Assets | $199.0K | $157.0K | $74.0K | |
| Current Assets | $116M | $153M | $97M | |
| Total Assets | $116M | $160M | $97M | |
| Accounts Payable | $1M | $1M | $186.0K | |
| Accrued Liabilities | $4M | $3M | $5M | |
| Current Liabilities | $5M | $4M | $6M | |
| Total Liabilities | · | $4M | $6M | |
| Paid-in Capital | $458M | $451M | $341M | |
| Retained Earnings | $-346M | $-295M | $-250M | |
| AOCI | $120.0K | $230.0K | $30.0K | |
| Stockholders' Equity | $111M | $156M | $91M | |
| Liabilities + Equity | $116M | $160M | $97M | |
| Shares Outstanding | · | · | 0 |
Nakit Akışı 6
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $5M | |
| Operating Cash Flow | $-46M | $-42M | $-24M | |
| Investing Cash Flow | $5M | $-62M | $13M | |
| Stock Issued | $0 | $106M | · | |
| Net Stock Activity | $0 | $106M | · | |
| Financing Cash Flow | $275.0K | $105M | $86M |
Kârlılık 5
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | · | -1537.0% | |
| Net Margin | · | · | -1393.8% | |
| EBITDA Margin | · | · | -1537.0% | |
| ROA | -36.9% | -35.5% | -43.0% | |
| ROE | -42.3% | -27.9% | -29.5% |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 22.8 | 34.3 | 17.1 | |
| Quick Ratio | 22.2 | 34.0 | 16.8 |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 |
Değerleme (TTM) 8
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | · | · | $2M | |
| Net Income TTM | $-51M | $-46M | $-28M | |
| Market Cap | · | · | $0 | |
| P/E | -3.7 | -3.1 | -2.0 | |
| P/S | · | · | 0.0 | |
| P / Tangible Book | · | · | 0.0 | |
| P / Cash Flow | · | · | 0.0 | |
| Earnings Yield | -26.7% | -32.2% | -49.1% |
Gelir Tablosu 12
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | $0 | $2M | |
| R&D Expense | $7M | $7M | $10M | $7M | $15M | $14M | $13M | $6M | $5M | $6M | $5M | |
| SG&A Expense | $5M | $4M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $12M | $11M | $14M | $12M | $20M | $18M | $17M | $11M | $9M | $9M | $9M | |
| Operating Income | $-12M | $-11M | $-14M | $-12M | $-20M | $-18M | $-17M | $-11M | $-9M | $-9M | $-7M | |
| Other Non-op | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Net Income | $-11M | $-10M | $-13M | $-10M | $-18M | $-16M | $-15M | $-8M | $-7M | $-8M | $-6M | |
| EPS (Basic) | $-0.33 | $-0.30 | $-0.40 | $-0.32 | $-0.56 | $-0.52 | $-0.45 | $-0.25 | $-0.23 | $69.07 | $-0.35 | |
| EPS (Diluted) | $-0.33 | $-0.30 | $-0.40 | $-0.32 | $-0.56 | $-0.52 | $-0.45 | $-0.25 | $-0.23 | $69.07 | $-0.35 | |
| Shares (Basic) | 32,559,704 | -64,510,079 | 32,464,893 | 32,195,366 | 32,195,345 | -61,745,925 | 32,143,336 | 31,913,887 | 29,039,427 | -8,109,004 | 18,194,682 | |
| Shares (Diluted) | 32,559,704 | -64,510,079 | 32,464,893 | 32,195,366 | 32,195,345 | -61,745,925 | 32,143,336 | 31,913,887 | 29,039,427 | -8,109,004 | 18,194,682 | |
| EBITDA | $-12M | · | $-14M | $-12M | $-20M | · | $-17M | $-11M | $-9M | · | $-7M |
Bilanço 17
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $35M | $32M | $42M | $65M | $76M | $77M | $96M | $177M | $75M | $102M | |
| Short-term Investments | $68M | $78M | $84M | $83M | $80M | $75M | $75M | $70M | $17M | $20M | $0 | |
| Prepaid Expense | $3M | $3M | $3M | $2M | $2M | $2M | $5M | $378.0K | $786.0K | $2M | $974.0K | |
| Other Current Assets | $248.0K | $199.0K | $253.0K | $173.0K | $263.0K | $157.0K | $101.0K | $130.0K | $108.0K | $74.0K | $77.0K | |
| Current Assets | $108M | $116M | $119M | $127M | $146M | $153M | $157M | $167M | $194M | $97M | $103M | |
| Other Non-current Assets | · | · | · | · | $62.0K | · | · | · | · | · | · | |
| Total Assets | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M | $195M | $97M | $103M | |
| Accounts Payable | $2M | $1M | $4M | $2M | $3M | $1M | $1M | $2M | $531.0K | $186.0K | $2M | |
| Accrued Liabilities | $3M | $4M | $5M | $5M | $4M | $3M | $3M | $4M | $4M | $5M | $3M | |
| Current Liabilities | $5M | $5M | $9M | $7M | · | $4M | · | · | · | $6M | $5M | |
| Total Liabilities | · | · | · | · | $7M | · | $4M | $6M | $5M | · | $5M | |
| Paid-in Capital | $459M | $458M | $456M | $454M | $452M | $451M | $449M | $448M | $446M | $341M | $339M | |
| Retained Earnings | $-357M | $-346M | $-337M | $-324M | $-313M | $-295M | $-279M | $-264M | $-256M | $-250M | $-242M | |
| AOCI | $8.0K | $120.0K | $117.0K | $76.0K | $121.0K | $230.0K | $441.0K | $-23.0K | $7.0K | $30.0K | · | |
| Stockholders' Equity | $102M | $111M | $119M | $130M | $139M | $156M | $171M | $183M | $190M | $91M | $98M | |
| Liabilities + Equity | $108M | $116M | $128M | $137M | $146M | $160M | $175M | $189M | $195M | $97M | $103M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | 0 | 0 |
Nakit Akışı 6
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $759.0K | $1M | $2M | |
| Operating Cash Flow | $-9M | $-12M | $-10M | $-9M | $-15M | $-11M | $-20M | $-6M | $-6M | $-7M | $-4M | |
| Investing Cash Flow | $10M | $14M | $75.0K | $-13M | $3M | $10M | $624.0K | $-75M | $3M | $-20M | $0 | |
| Stock Issued | · | $0 | $0 | · | · | $0 | $0 | $0 | $106M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $106M | · | · | |
| Financing Cash Flow | · | $0 | $274.0K | · | · | $0 | $0 | $-27.0K | $105M | $0 | $87M |
Kârlılık 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -372.6% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -317.6% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -372.6% | |
| ROA | -8.4% | · | -8.5% | -6.4% | -10.7% | · | -10.5% | -7.7% | -6.8% | · | -12.3% | |
| ROE | -8.8% | · | -8.9% | -6.6% | -11.1% | · | -10.9% | 107.4% | -7.0% | · | -13.0% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.3 | · | 13.1 | 17.6 | · | · | · | · | · | · | 20.4 | |
| Quick Ratio | 19.7 | · | 12.8 | 17.3 | · | · | · | · | · | · | 20.2 |
Verimlilik 1
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 |
Değerleme (TTM) 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-52M | · | $-56M | $-51M | $-48M | · | $-36M | $-28M | $-26M | · | $-27M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | $0 | |
| P/E | -3.2 | · | -4.0 | -4.8 | -2.2 | · | -2.2 | -0.1 | -0.1 | · | -0.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Earnings Yield | -30.8% | · | -25.2% | -20.7% | -45.7% | · | -46.2% | -1071.0% | -1327.7% | · | -1273.5% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Gelir | — | — | $2M | — |
| Faaliyet Kâr Marjı % | — | — | -1537.0% | — |
| Net Gelir | $-51M | $-46M | $-28M | $-30M |
| Seyreltilmiş Hisse Başı Kâr | $-1.58 | $-1.45 | $-2.66 | $-165.20 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Cari Oran | 22.8 | 34.3 | 17.1 | — |
| Cari Oran | 22.2 | 34.0 | 16.8 | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.